Worth reading
44Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
210000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Large-scale exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
Who receives how much
New shares: 210,000; treasury shares transferred: 0
EVO FUND (allottee of the 16th Series of Stock Acquisition Rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
¥416, ¥425 and ¥436 (exercise prices during the period); details of the adjustment clauses and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 17,000; unexercised as of 31 July 2026: 2,100; unexercised as of the current date: 0
Most recent equity financing
Timing 1 August 2025 / Type Issuance of the 16th Series of Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clauses) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Large-scale exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | New shares: 210,000; treasury shares transferred: 0 |
| Intended allottee | EVO FUND (allottee of the 16th Series of Stock Acquisition Rights) |
| Total number of issued shares | 8,383,200 shares (as of 30 July 2026, including 183 treasury shares) → Not disclosed |
| Exercise price | ¥416, ¥425 and ¥436 (exercise prices during the period); details of the adjustment clauses and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 17,000; unexercised as of 31 July 2026: 2,100; unexercised as of the current date: 0 |
| Most recent equity financing | Timing 1 August 2025 / Type Issuance of the 16th Series of Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clauses) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To announce the bulk exercise of these stock acquisition rights during the period from 1 August to 27 August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.